A novel minimal model to describe NEFA kinetics following an intravenous glucose challenge

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 294, Issue 4, 2008, Pages

  Boston, Ray C ^a,b   Moate, Peter J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Compartmental model; Glucose tolerance test

Indexed keywords

FATTY ACID; GLUCOSE;

ARTICLE; COMPARTMENT MODEL; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPOLYSIS; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INFUSIONS, INTRAVENOUS; KINETICS; LIPOLYSIS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 41749097427     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00749.2007     Document Type: Article

References (46)

1. An P, Teran-Garcia M, Rice T, Rankinen T, Weisnagel SJ, Bergman RN, Boston RC, Mandel S, Stefanovski D, Leon AS, Skinner JS, Rao DC, Bouchard C. Genome-wide linkage scans for prediabetes phenotypes in response to 20 wk of endurance exercise training in non-diabetic whites and blacks: the HERITAGE Family Study. Diabetologia 48: 1142-1149, 2005.
2. Arner P, Bolinder J, Ostman J. Glucose stimulation of the antilipolytic effect of insulin in humans. Science 220: 1057-1059, 1983.
3. Bergman RN. Minimal model: perspective from 2005. Horm Res 64, Suppl 3: 8-15, 2005.
4. Bergman RN, Bowden CR. The minimal model approach to quantification of factors controlling glucose disposal in man. In: Carbohydrate Metabolism. New York: Wiley, 1981, p. 269-296.
5. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol Endocrinol Metab 236: E667-E677, 1979.
6. Bjorntorp P. Fatty acids, hyperinsulinemia and insulin resistance: which comes first. Curr Opin Lipidol 5: 166-174, 1994.
7. Bjorntorp P, Bergman H, Varnauskas E. Plasma free fatty acid turnover in obesity. Acta Med Scand 185: 351-356, 1969.
8. Boden G, Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96: 1261-1268, 1995.
9. Boden G, Jadal F. Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes 40: 686-692, 1991.
10. Boston RC, Roche JR, Ward GW, Moate PJ. A novel "Minimal Model" to describe non-esterified fatty acid kinetics in Holstein dairy cows. J Dairy Res 75: 13-18, 2008.
11. Brehm A, Thomaseth K, Bernroider E, Nowotny E, Waldhausl W, Pacini G, Roden M. The role of endocrine counterregulation for estimating insulin sensitivity from intravenous glucose tolerance tests. J Clin Endocrinol Metab 91: 2272-2278, 2006.
12. Chlouverakis C. The action of glucose on lipolysis. Metabolism 16: 469-472, 1967.
13. Coggan AR, Raguso CA, Gastaldelli A, Sidossis LS, Yeckel CW. Fat metabolism during high-intensity exercise in endurance -trained and un-trained men. Metabolism 49: 122-128, 2000.
14. Coppack SW, Jensen MD, Miles JM. In vivo regulation of lipolysis in humans. J Lipid Res 35: 177-193, 1994.
15. Efendic S, Ostman J. Catecholamines and metabolism of human adipose tissue. IV. Influence of glucose on catecholamine-induced lipolysis in human omental tissue in vitro. Acta Med Scand 187: 485-491, 1970.
16. Fabian E, Fabian F, Stork A, Kucerova L, Fabianova J. Matematiký model ploesu hladiny neesteifkovaných mastných kyselin po glukóze u zdravých osob a cirhotiků [Mathematical model of the decrease in the level of non-esterified fatty acids after glucose in healthy individuals and in Cirrhotics]. Sborn Léek 73: 71-75, 1971.
17. Ferrannini ES, Camastra S, Coppack SW, Flisher D, Golay A, Mitrakou A. Insulin action and non-esterified fatty acids. Proc Nutr Soc 56: 753-761, 1997.
18. Frank PM. Introduction to System Sensitivity Theory. New York: Academic, 1978.
19. Frayn KN. Regulation of fatty acid delivery in vivo. Adv Exp Med Biol 44: 171-179, 1998.
20. Frayn KN, Coppack SW, Fielding BA, Humphreys SM. Coordinated regulation of hormone-sensitive lipase and lipoprotein lipase in human adipose tissue in vivo: implications for the control of fat storage and fat mobilization. Adv Enzyme Regul 35: 163-178, 1995.
21. Gerich JE, Charles MA, Grodsky GM. Characterization of the effects of arginine and glucose on glucagon and insulin release from perfused rat pancreas. J Clin Invest 54: 833-841.
22. Groop LC, Ferrannini E. Insulin action and substrate competition. Baillieres Clin Endocrinol Metab 7: 1007-1032, 1993.
23. Hallidin MU, Brismar K, Tuvemo T, Gustafsson J. Insulin sensitivity and lipolysis in adolescent girls with poorly controlled type 1 diabetes: effect of anticholinergic treatment. Clin Endocrinol 57: 735-743, 2002.
24. Ikkos D, Luft R. On the intravenous glucose tolerance test. Acta Endocrinol 25: 312-34, 1957.
25. Kissebah AH, Alfarsi S, Adans PW, Wynn W. Role of insulin resistance in adipose tissue in the pathogenesis of endogenous hypertriglyceridemia in man. Diabetologia 12: 563-571, 1976.
26. Klein S, Coyle EF, Wolfe RR. Effect of exercise on lipolytic sensitivity in endurance trained athletes. J Appl Physiol 78: 2201-2206, 1995.
27. Klein S, Young VR, Blackburn GL, Bistrian Wolfe RR BR. The impact of body composition on the regulation of lipolysis during short-term fasting. J Am Coll Nutr 7: 77-84, 1988.
28. Laville M, Rigalleau V, Riou JP, Beylot M. Respective role of plasma nonesterified fatty acid oxidation and total lipid oxidation in lipid-induced insulin resistance. Metabolism 44: 639-644, 1995.
29. Moate PJ, Roche JR, Chagas L, Boston RC. Evaluation of a compartmental model to describe non-esterified fatty acid kinetics in Holstein dairy cows. J Dairy Res 74: 430-437, 2007.
30. Panunzi S, Palumbo P, De Gaetano A. A discrete single delay model for the intravenous glucose tolerance test. Theor Biol Med Model 4: doi:10.1186/1742-4682-4-35.2007.
31. Park KS, Rhee BD, Lee KU, Lee HK, Koh CS, Min HK. Hyperglycemia per se can reduce plasma free fatty acid and glycerol levels in the acutely insulin deficient dog. Metabolism 39: 595-597, 1990.
32. Pilz S, Scharnagl H, Tiran B, Seelhorst U, Wellnitz B, Boehm BO, Schaefer JR, Marz W. Free fatty acids are independently associated with all-cause and cardiovascular mortality in subjects with coronary artery disease. J Clin Endocrinol Metab 91: 2542-2547, 2006.
33. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty acid cycle: its role in insulin sensitivity and metabolic disturbances of diabetes mellitus. Lancet 1: 785-789, 1963.
34. Roy A, Parker RS. Dynamic modeling of free fatty acid, glucose and insulin: an extended "Minimal Model". Diabetes Technol Ther 8: 617-626, 2006.
35. Sarafidis PA, Bakris GL. Non-esterified fatty acids and blood pressure elevation: a mechanism for hypertension in subjects with obesity/ insulin resistance? J Hum Hypertens 21: 12-19, 2007.
36. Schneeberg NG, Finestone I. The effect of age on the intravenous glucose tolerance test. J Gerontol 7: 54-60, 1952.
37. Srinivasan R, Kadish AH, Sridhar R. A mathematical model for the control mechanism of free fatty acid-glucose metabolism in normal humans. Comput Biomed Res 3: 146-166, 1970.
38. St. Pierre NR. Reassessment of biases in predicted nitrogen flows to the duodenum by NRC 2001. J Dairy Sci 86: 344-350, 2003.
39. Sumner AE, Bergman RN, Vega GL, Genovese DJ, Cochran CS, Pacak K, Watanabe RM, Boston RC. The multiphasic profile of free fatty acids during the intravenous glucose tolerance test is unresponsive to exogenous insulin. Metabolism 53: 1202-1207, 2004.
40. Tepperman J, Tepperman HM. Gluconeogenesis, lipogenesis and the Sherringtonian metaphor. Fed Proc 29: 1284-1293, 1970.
41. Thomaseth K, Pavan A. Model-based analysis of glucose and free fatty acid kinetics during glucose tolerance tests. In: Mathematical Modeling in Nutrition and Toxicology. edited by Hargrove JL and Berdanier CD. Athens, GA: Mathematical Biology, 2003, p. 21-40.
42. Ward GM, Walters JM, Barton J, Alford FP, Boston RC. Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment. Metabolism 50: 512-519, 2001.
43. Wastney ME, Patterson BH, Linares OA, Greif PC, Boston RC. Investigating Biological Systems Using Modeling-Strategies and Software. San Diego, CA: Academic, 1999.
44. Yang YJ, Hope ID, Ader M, Bergman RN. Importance of transcapillary insulin transport to dynamics of insulin action after intravenous glucose. Am J Physiol Endocrinol Metab 266: E17-E25, 1994.
45. Zambon A, Hashimoto SI, Brunzell JD. Analysis of techniques to obtain plasma for measurement of levels of free fatty acids. J Lipid Res 34: 1021-1028, 1993.
46. Zoratti R, Godsland IF, Chaturvedi N, Crook D, Stevenson JC, McKeigue PM. Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease. Metabolism 49: 245-252, 2000.